Over the past four months, I’ve spoken to dozens of biomedical researchers either at NIH, other government grant-making agencies or at the various American research institutions which receive U.S. government grants. Over that time, I’ve developed at least a very rudimentary understanding of the nitty-gritty mechanics of the grant-making relationship between agencies and research institutions. What I’ve learned is a fascinating and critically important dynamic operating just beneath the surface of theWhite House’s whole war on biomedical research specifically and universities generally. The world of biomedical research actually has immense latent political power, albeit largely untapped. Researchers have a much stronger hand politically and the White House’s position, in terms of public opinion, is comparatively weak.

The problem is that the world of biomedical research has close to no experience operating in a political context and especially in the context of mass politics. Much of the world of biomedical research operates through channels of review and funding connecting a few government grant-making institutions to the nationwide archipelago of research institutions and universities. Operating within those channels is so basic to the mores and experience of the research and university world that researchers have in many cases kept trying to operate within them (rebooting them, checking them for unknown clogs) long after the White House has broken them and moved on. The White House has relied on researchers’ unfamiliarity with political fights, using their sole reliance on bureaucratic channels of funding and review — which the universities and the federal government set up together going on a century ago — against them. The only other pathways through which researchers tend to assert themselves are professional organizations, very non-mass politics entities which, in ordinary times, would speak to the relevant members of Congress.

You’ve seen our liveblog, which provides a detailed and technical look at today’s birthright citizenship oral arguments before the Supreme Court. I want to focus on a broad and critical issue. The Trump administration brought this to the Supreme Court. While the underlying or substantive issue is birthright citizenship, they were not seeking to have that issue resolved. They wanted the Court to address whether federal trial courts can issue national injunctions binding the hands of the incumbent administration. 

I want to thank everyone who came out to see Kate Riga and me at our live podcast event last night in Chicago. You made us feel very welcome and we had a great time. And it was great meeting so many of you at the happy hour after the event. This was our first TPM event outside our home stomping grounds in New York City and Washington, DC. We were so happy with how it went.